{"entity":{"type":"insider","cik":"0001379218","url":"/insider/0001379218","json_url":"/insider/0001379218.json","name":"Vander Vort John","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":29,"n_filings":18,"first":"2007-01-05","last":"2015-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Vander Vort John","source":"filing","n_filings":18,"first_seen":"2007-01-05","last_seen":"2015-03-06"}],"transactions":[{"id":8068050,"accession":"0001209191-15-023723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-023723","line_url":"/filing/0001209191-15-023723#line-1","is_derivative":false,"issuer_cik":"0001379218","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001379218","owner_cik":"0001379218","owner_name":"Vander Vort John","owner_display_name":"Vander Vort John","owner_url":"/insider/0001379218","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6137.0,"shares_display":"6,137","price_per_share":20.0059,"price_display":"20.01","price_state":"stated","total_value":122776.2083,"total_display":"122,776.21","total_whole":"122,776","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-06","filed_date":"2015-03-06","scope":"insider"},{"id":4505340,"accession":"0001209191-13-038629","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-038629","line_url":"/filing/0001209191-13-038629#line-3","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"Conatus Pharmaceuticals Inc","issuer_ticker":"CNAT","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"Vander Vort John; KAILIAN VAUGHN M; GADICKE ANSBERT; EVNIN LUKE; Foley Todd","owner_display_name":"Vander Vort John","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":165265.0,"shares_display":"165,265","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":1817915.0,"total_display":"1,817,915.00","total_whole":"1,817,915","shares_owned_after":1192080.0,"shares_owned_after_display":"1,192,080","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-30","filed_date":"2013-08-01","scope":"insider"},{"id":5040970,"accession":"0001209191-13-034986","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-034986","line_url":"/filing/0001209191-13-034986#line-4","is_derivative":false,"issuer_cik":"0001379218","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001379218","owner_cik":"0001379218","owner_name":"Vander Vort John","owner_display_name":"Vander Vort John","owner_url":"/insider/0001379218","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":4351050.0,"shares_owned_after_display":"4,351,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-07-02","filed_date":"2013-07-02","scope":"insider"},{"id":5220395,"accession":"0001209191-13-016170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-016170","line_url":"/filing/0001209191-13-016170#line-1","is_derivative":false,"issuer_cik":"0001356950","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001356950","owner_cik":null,"owner_name":"MPM BioVentures IV GmbH & Co. Beteiligungs KG; Vander Vort John; Scopa James Paul; MPM BioVentures IV GP LLC; Foley Todd; MPM Asset Management Investors BV4 LLC; MPM BioVentures IV QP LP; MPM BioVentures IV LLC","owner_display_name":"MPM BioVentures IV GmbH & Co. Beteiligungs KG","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500000.0,"shares_display":"500,000","price_per_share":27.86,"price_display":"27.86","price_state":"stated","total_value":13930000.0,"total_display":"13,930,000.00","total_whole":"13,930,000","shares_owned_after":2790479.0,"shares_owned_after_display":"2,790,479","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-03-11","filed_date":"2013-03-13","scope":"insider"},{"id":2743349,"accession":"0001209191-12-007620","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-007620","line_url":"/filing/0001209191-12-007620#line-1","is_derivative":false,"issuer_cik":"0001134657","issuer_name":"Verastem, Inc.","issuer_ticker":"VSTM","issuer_name_source":null,"issuer_url":"/issuer/0001134657","owner_cik":null,"owner_name":"EVNIN LUKE; Scopa James Paul; MPM BIOVENTURES V, L.P.; MPM ASSET MANAGEMENT INVESTORS BV5 LLC; St Peter Steven; MPM BIOVENTURES V LLC; Vander Vort John; KAILIAN VAUGHN M; MPM BIOVENTURES V GP LLC; Foley Todd","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stoc","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","total_whole":"1,000,000","shares_owned_after":2033333.0,"shares_owned_after_display":"2,033,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-02-01","filed_date":"2012-02-03","scope":"insider"},{"id":8835368,"accession":"0001209191-11-057585","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-057585","line_url":"/filing/0001209191-11-057585#line-1","is_derivative":false,"issuer_cik":"0001352447","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001352447","owner_cik":null,"owner_name":"MPM BioVentures IV GmbH & Co. Beteiligungs KG; MPM BioVentures IV GP LLC; MPM Asset Management Investors BV4 LLC; Scopa James Paul; Foley Todd; MPM BioVentures IV QP LP; MPM BioVentures IV LLC; Vander Vort John; St Peter Steven","owner_display_name":"MPM BioVentures IV GmbH & Co. Beteiligungs KG","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":461538.0,"shares_display":"461,538","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":2999997.0,"total_display":"2,999,997.00","total_whole":"2,999,997","shares_owned_after":3290479.0,"shares_owned_after_display":"3,290,479","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-11-21","filed_date":"2011-11-22","scope":"insider"},{"id":9267660,"accession":"0001209191-11-010540","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-010540","line_url":"/filing/0001209191-11-010540","is_derivative":false,"issuer_cik":"0001352447","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001352447","owner_cik":null,"owner_name":"DOMBKOWSKI ASHLEY L; Greene William; MPM Asset Management Investors BV4 LLC; MPM BioVentures IV GP LLC; MPM BioVentures IV GmbH & Co. Beteiligungs KG; MPM BioVentures IV LLC; MPM BioVentures IV QP LP; Scopa James Paul; St Peter Steven; Vander Vort John","owner_display_name":"DOMBKOWSKI ASHLEY L","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":535714.0,"shares_display":"535,714","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":3749998.0,"total_display":"3,749,998.00","total_whole":"3,749,998","shares_owned_after":2561084.0,"shares_owned_after_display":"2,561,084","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-08","filed_date":"2011-02-17","scope":"insider","n_lines":2},{"id":5719024,"accession":"0001209191-09-008572","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-008572","line_url":"/filing/0001209191-09-008572#line-2","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; MPM BioVentures Strategic Fund LP; KAILIAN VAUGHN M; DOMBKOWSKI ASHLEY L; MPM Asset Management Investors 2004 BVIII LLC; St Peter Steven; GADICKE ANSBERT; EVNIN LUKE; Greene William","owner_display_name":"Vander Vort John","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1249.0,"shares_display":"1,249","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":10241.8,"total_display":"10,241.80","total_whole":"10,242","shares_owned_after":3419056.0,"shares_owned_after_display":"3,419,056","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-12","filed_date":"2009-02-12","scope":"insider"},{"id":5719023,"accession":"0001209191-09-008572","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-008572","line_url":"/filing/0001209191-09-008572#line-1","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; MPM BioVentures Strategic Fund LP; KAILIAN VAUGHN M; DOMBKOWSKI ASHLEY L; MPM Asset Management Investors 2004 BVIII LLC; St Peter Steven; GADICKE ANSBERT; EVNIN LUKE; Greene William","owner_display_name":"Vander Vort John","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":999.0,"shares_display":"999","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":7992.0,"total_display":"7,992.00","total_whole":"7,992","shares_owned_after":3417807.0,"shares_owned_after_display":"3,417,807","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-11","filed_date":"2009-02-12","scope":"insider"},{"id":5938118,"accession":"0001209191-09-007923","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-007923","line_url":"/filing/0001209191-09-007923#line-1","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"DOMBKOWSKI ASHLEY L; MPM Asset Management Investors 2004 BVIII LLC; KAILIAN VAUGHN M; St Peter Steven; MPM BioVentures Strategic Fund LP; GADICKE ANSBERT; EVNIN LUKE; Greene William; Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP","owner_display_name":"DOMBKOWSKI ASHLEY L","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":999.0,"shares_display":"999","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":7992.0,"total_display":"7,992.00","total_whole":"7,992","shares_owned_after":3416808.0,"shares_owned_after_display":"3,416,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-09","filed_date":"2009-02-10","scope":"insider"},{"id":5759687,"accession":"0001209191-09-007153","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-007153","line_url":"/filing/0001209191-09-007153#line-1","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"EVNIN LUKE; Greene William; GADICKE ANSBERT; St Peter Steven; MPM BioVentures Strategic Fund LP; Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; KAILIAN VAUGHN M; DOMBKOWSKI ASHLEY L; MPM Asset Management Investors 2004 BVIII LLC","owner_display_name":"EVNIN LUKE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2648.0,"shares_display":"2,648","price_per_share":7.8,"price_display":"7.80","price_state":"stated","total_value":20654.4,"total_display":"20,654.40","total_whole":"20,654","shares_owned_after":3415809.0,"shares_owned_after_display":"3,415,809","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-05","filed_date":"2009-02-06","scope":"insider"},{"id":5718964,"accession":"0001209191-09-005046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-005046","line_url":"/filing/0001209191-09-005046","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"MPM Asset Management Investors 2004 BVIII LLC; St Peter Steven; Greene William; EVNIN LUKE; Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; GADICKE ANSBERT; MPM BioVentures Strategic Fund LP; DOMBKOWSKI ASHLEY L; KAILIAN VAUGHN M","owner_display_name":"MPM Asset Management Investors 2004 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1678.0,"shares_display":"1,678","price_per_share":8.174016686531585,"price_display":"8.17","price_state":"stated","total_value":13716.0,"total_display":"13,716.00","total_whole":"13,716","shares_owned_after":3412431.0,"shares_owned_after_display":"3,412,431","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-27","filed_date":"2009-01-27","scope":"insider","n_lines":2},{"id":5718962,"accession":"0001209191-09-005046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-005046","line_url":"/filing/0001209191-09-005046#line-1","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"MPM Asset Management Investors 2004 BVIII LLC; St Peter Steven; Greene William; EVNIN LUKE; Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; GADICKE ANSBERT; MPM BioVentures Strategic Fund LP; DOMBKOWSKI ASHLEY L; KAILIAN VAUGHN M","owner_display_name":"MPM Asset Management Investors 2004 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6029.0,"shares_display":"6,029","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":48232.0,"total_display":"48,232.00","total_whole":"48,232","shares_owned_after":3411483.0,"shares_owned_after_display":"3,411,483","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-23","filed_date":"2009-01-27","scope":"insider"},{"id":5759568,"accession":"0001209191-09-004708","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-004708","line_url":"/filing/0001209191-09-004708","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"MPM Asset Management Investors 2004 BVIII LLC; EVNIN LUKE; Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; KAILIAN VAUGHN M; St Peter Steven; MPM BioVentures Strategic Fund LP; GADICKE ANSBERT; Greene William; DOMBKOWSKI ASHLEY L","owner_display_name":"MPM Asset Management Investors 2004 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2583.0,"shares_display":"2,583","price_per_share":8.096709252806814,"price_display":"8.10","price_state":"stated","total_value":20913.8,"total_display":"20,913.80","total_whole":"20,914","shares_owned_after":3405454.0,"shares_owned_after_display":"3,405,454","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-22","filed_date":"2009-01-23","scope":"insider","n_lines":2},{"id":5759562,"accession":"0001209191-09-004708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-004708","line_url":"/filing/0001209191-09-004708#line-1","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"MPM Asset Management Investors 2004 BVIII LLC; EVNIN LUKE; Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; KAILIAN VAUGHN M; St Peter Steven; MPM BioVentures Strategic Fund LP; GADICKE ANSBERT; Greene William; DOMBKOWSKI ASHLEY L","owner_display_name":"MPM Asset Management Investors 2004 BVIII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":932.0,"shares_display":"932","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":7456.0,"total_display":"7,456.00","total_whole":"7,456","shares_owned_after":3402871.0,"shares_owned_after_display":"3,402,871","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-21","filed_date":"2009-01-23","scope":"insider"},{"id":5709720,"accession":"0001209191-09-003975","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-003975","line_url":"/filing/0001209191-09-003975#line-4","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"KAILIAN VAUGHN M; MPM BioVentures Strategic Fund LP; EVNIN LUKE; Greene William; MPM Asset Management Investors 2004 BVIII LLC; DOMBKOWSKI ASHLEY L; GADICKE ANSBERT; Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; St Peter Steven","owner_display_name":"KAILIAN VAUGHN M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45.0,"shares_display":"45","price_per_share":8.4,"price_display":"8.40","price_state":"stated","total_value":378.0,"total_display":"378.00","total_whole":"378","shares_owned_after":3401939.0,"shares_owned_after_display":"3,401,939","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-20","filed_date":"2009-01-20","scope":"insider"},{"id":5709719,"accession":"0001209191-09-003975","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-09-003975","line_url":"/filing/0001209191-09-003975#line-3","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"KAILIAN VAUGHN M; MPM BioVentures Strategic Fund LP; EVNIN LUKE; Greene William; MPM Asset Management Investors 2004 BVIII LLC; DOMBKOWSKI ASHLEY L; GADICKE ANSBERT; Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; St Peter Steven","owner_display_name":"KAILIAN VAUGHN M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":899.0,"shares_display":"899","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":7371.8,"total_display":"7,371.80","total_whole":"7,372","shares_owned_after":3401894.0,"shares_owned_after_display":"3,401,894","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-19","filed_date":"2009-01-20","scope":"insider"},{"id":5709718,"accession":"0001209191-09-003975","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-09-003975","line_url":"/filing/0001209191-09-003975#line-2","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"KAILIAN VAUGHN M; MPM BioVentures Strategic Fund LP; EVNIN LUKE; Greene William; MPM Asset Management Investors 2004 BVIII LLC; DOMBKOWSKI ASHLEY L; GADICKE ANSBERT; Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; St Peter Steven","owner_display_name":"KAILIAN VAUGHN M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7340.0,"shares_display":"7,340","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":60188.0,"total_display":"60,188.00","total_whole":"60,188","shares_owned_after":3400995.0,"shares_owned_after_display":"3,400,995","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-16","filed_date":"2009-01-20","scope":"insider"},{"id":5709717,"accession":"0001209191-09-003975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-003975","line_url":"/filing/0001209191-09-003975#line-1","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"KAILIAN VAUGHN M; MPM BioVentures Strategic Fund LP; EVNIN LUKE; Greene William; MPM Asset Management Investors 2004 BVIII LLC; DOMBKOWSKI ASHLEY L; GADICKE ANSBERT; Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; St Peter Steven","owner_display_name":"KAILIAN VAUGHN M","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1598.0,"shares_display":"1,598","price_per_share":7.8,"price_display":"7.80","price_state":"stated","total_value":12464.4,"total_display":"12,464.40","total_whole":"12,464","shares_owned_after":3393655.0,"shares_owned_after_display":"3,393,655","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-15","filed_date":"2009-01-20","scope":"insider"},{"id":5718939,"accession":"0001209191-09-003416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-09-003416","line_url":"/filing/0001209191-09-003416#line-1","is_derivative":false,"issuer_cik":"0001134655","issuer_name":"PEPLIN INC","issuer_ticker":"PLIN","issuer_name_source":null,"issuer_url":"/issuer/0001134655","owner_cik":null,"owner_name":"Vander Vort John; MPM BIOVENTURES III PARALLEL FUND, LP; GADICKE ANSBERT; Greene William; EVNIN LUKE; MPM BioVentures Strategic Fund LP; St Peter Steven; KAILIAN VAUGHN M; DOMBKOWSKI ASHLEY L; MPM Asset Management Investors 2004 BVIII LLC","owner_display_name":"Vander Vort John","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6911.0,"shares_display":"6,911","price_per_share":7.03,"price_display":"7.03","price_state":"stated","total_value":48584.33,"total_display":"48,584.33","total_whole":"48,584","shares_owned_after":3392057.0,"shares_owned_after_display":"3,392,057","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-01-13","filed_date":"2009-01-15","scope":"insider"},{"id":7028298,"accession":"0001209191-07-053964","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-053964","line_url":"/filing/0001209191-07-053964#line-1","is_derivative":false,"issuer_cik":"0001062216","issuer_name":"MEMORY PHARMACEUTICALS CORP","issuer_ticker":"MEMY","issuer_name_source":null,"issuer_url":"/issuer/0001062216","owner_cik":null,"owner_name":"DOMBKOWSKI ASHLEY L; Vander Vort John; KAILIAN VAUGHN M; St Peter Steven; GADICKE ANSBERT; Greene William; EVNIN LUKE; Scopa James Paul","owner_display_name":"DOMBKOWSKI ASHLEY L","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27600.0,"shares_display":"27,600","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":57960.0,"total_display":"57,960.00","total_whole":"57,960","shares_owned_after":14138993.0,"shares_owned_after_display":"14,138,993","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-09-14","filed_date":"2007-09-18","scope":"insider"},{"id":7702647,"accession":"0001209191-07-053453","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-053453","line_url":"/filing/0001209191-07-053453#line-2","is_derivative":false,"issuer_cik":"0001062216","issuer_name":"MEMORY PHARMACEUTICALS CORP","issuer_ticker":"MEMY","issuer_name_source":null,"issuer_url":"/issuer/0001062216","owner_cik":null,"owner_name":"St Peter Steven; KAILIAN VAUGHN M; Greene William; Vander Vort John; GADICKE ANSBERT; DOMBKOWSKI ASHLEY L; EVNIN LUKE; Scopa James Paul","owner_display_name":"St Peter Steven","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62180.0,"shares_display":"62,180","price_per_share":2.1248,"price_display":"2.12","price_state":"stated","total_value":132120.064,"total_display":"132,120.06","total_whole":"132,120","shares_owned_after":14166593.0,"shares_owned_after_display":"14,166,593","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-09-13","filed_date":"2007-09-14","scope":"insider"},{"id":7702646,"accession":"0001209191-07-053453","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-053453","line_url":"/filing/0001209191-07-053453#line-1","is_derivative":false,"issuer_cik":"0001062216","issuer_name":"MEMORY PHARMACEUTICALS CORP","issuer_ticker":"MEMY","issuer_name_source":null,"issuer_url":"/issuer/0001062216","owner_cik":null,"owner_name":"St Peter Steven; KAILIAN VAUGHN M; Greene William; Vander Vort John; GADICKE ANSBERT; DOMBKOWSKI ASHLEY L; EVNIN LUKE; Scopa James Paul","owner_display_name":"St Peter Steven","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":2.1611,"price_display":"2.16","price_state":"stated","total_value":21611.0,"total_display":"21,611.00","total_whole":"21,611","shares_owned_after":14228773.0,"shares_owned_after_display":"14,228,773","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-09-12","filed_date":"2007-09-14","scope":"insider"},{"id":7106796,"accession":"0001181431-07-002395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-07-002395","line_url":"/filing/0001181431-07-002395#line-1","is_derivative":false,"issuer_cik":"0001062216","issuer_name":"MEMORY PHARMACEUTICALS CORP","issuer_ticker":"MEMY","issuer_name_source":null,"issuer_url":"/issuer/0001062216","owner_cik":null,"owner_name":"Greene William; DOMBKOWSKI ASHLEY L; EVNIN LUKE; Scopa James Paul; St Peter Steven; Vander Vort John; KAILIAN VAUGHN M; GADICKE ANSBERT","owner_display_name":"Greene William","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2315151.0,"shares_display":"2,315,151","price_per_share":1.11,"price_display":"1.11","price_state":"stated","total_value":2569817.61,"total_display":"2,569,817.61","total_whole":"2,569,818","shares_owned_after":11391019.0,"shares_owned_after_display":"11,391,019","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-12-18","filed_date":"2007-01-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001509190","name":"ARATANA THERAPEUTICS, INC.","url":"/issuer/0001509190","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2013-07-02","last_seen":"2015-03-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001383701","name":"Conatus Pharmaceuticals Inc","url":"/issuer/0001383701","role":"Ten percent owner","n_filings":1,"first_seen":"2013-08-01","last_seen":"2013-08-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001396814","name":"Pacira Pharmaceuticals, Inc.","url":"/issuer/0001396814","role":"Ten percent owner, Other","n_filings":4,"first_seen":"2011-02-10","last_seen":"2013-03-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001526119","name":"Verastem, Inc.","url":"/issuer/0001526119","role":"Other","n_filings":1,"first_seen":"2012-02-03","last_seen":"2012-02-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001408808","name":"PEPLIN INC","url":"/issuer/0001408808","role":"Ten percent owner","n_filings":7,"first_seen":"2009-01-15","last_seen":"2009-02-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001062216","name":"MEMORY PHARMACEUTICALS CORP","url":"/issuer/0001062216","role":"Ten percent owner","n_filings":3,"first_seen":"2007-01-05","last_seen":"2007-09-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001379218","retrieved_at":"2026-08-23T01:21:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}